Efficacy of brimonidine & latanoprost in treatment normal tension glaucoma
Phase 2
Recruiting
- Conditions
- ormal Tension Glaucoma.Glaucoma
- Registration Number
- IRCT20120817010617N7
- Lead Sponsor
- Zahedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients referring to Alzahra Ophthalmology Clinic, Who will be diagnosed with Normal Tension Glaucoma
Exclusion Criteria
patients on treatment
patients with drug allergy
eye surgery
past ophthalmologic diseases history
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method IOP (intraocular pressure ) mmhg. Timepoint: At the beginning of the study, Then 3 months, 6 months, 9 months and 12 months after initiating medications. Method of measurement: The Air puff tonometer Topcon.;Laminar and prelaminar thickness of lamina cribrosa using OCT of optic nerve head(ONH). Timepoint: At the beginning of the study, Then 3 months, 6 months, 9 months and 12 months after initiating medications. Method of measurement: laminar and prelaminar thickness of optic nerve head using cirrus OCT.;Visual field defect / number of scotomas and in decibels. Timepoint: At the beginning of the study, 6 months, and 12 months after initiating medications. Method of measurement: Humphrey field analyzer.
- Secondary Outcome Measures
Name Time Method